ALEAH GALLEGOS: Open Payments
NPI 1013752773 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,110 in 50 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $280 · 2025 $1,110
Food & beverage: $1,110
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $224 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Neurocrine BioSciences, Inc. | 5 | $103 |
| Lundbeck LLC | 5 | $98 |
| ABBVIE INC. | 4 | $80 |
| E.R. Squibb & Sons, L.L.C. | 4 | $70 |
| Alkermes, Inc. | 3 | $66 |
| Luye Pharma (USA) Ltd. | 2 | $58 |
| Janssen Pharmaceuticals, Inc | 3 | $55 |
| Supernus Pharmaceuticals, Inc. | 3 | $52 |
Products named: REXULTI, Auvelity, INGREZZA, VRAYLAR, COBENFY, ERZOFRI EXTENDED-RELEASE, Qelbree, FANAPT.
Industry payments across OH — which companies pay providers there.
